Leukocyte Ig-like receptor B1 restrains dendritic cell function through increased expression of the NF-κB regulator ABIN1/TNIP1

Journal of Leukocyte Biology

Volumn 100, Issue 4, 2016, Pages 737-746

  Khanolkar, Rahul C ^a   Kalogeropoulos, Michail ^a   Lawrie, Alistair ^a   Roghanian, Ali ^b,c   Vickers, Mark A ^a   Young, Neil T ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

DC maturation; Immunosuppression; Inhibitory receptor; LILRB1; Lymphoma

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN RECEPTOR; LEUKOCYTE IMMUNOGLOBULIN LIKE RECEPTOR B1; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA INDUCED PROTEIN 3 INTERACTING PROTEIN 1; UNCLASSIFIED DRUG; CYTOKINE; DNA BINDING PROTEIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 4; LEUKOCYTE ANTIGEN; LILRB1 PROTEIN, HUMAN; RECOMBINANT PROTEIN; TNIP1 PROTEIN, HUMAN;

ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; AUTOIMMUNE DISEASE; CELL DIFFERENTIATION; CELL FUNCTION; CELL SURFACE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; ENZYME PHOSPHORYLATION; GENE EXPRESSION; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IN VITRO STUDY; LEUKOCYTE; MONOCYTE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SINGLE NUCLEOTIDE POLYMORPHISM; T LYMPHOCYTE; BIOSYNTHESIS; BLOOD; CELL CULTURE; CELL NUCLEUS; CYTOLOGY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; METABOLISM; MYELOPOIESIS; PHAGOCYTOSIS; PHYSIOLOGY; PROTEIN TRANSPORT; RNA INTERFERENCE; SECRETION (PROCESS);

ANTIGEN PRESENTATION; ANTIGENS, CD; CELL NUCLEUS; CELLS, CULTURED; CYTOKINES; DENDRITIC CELLS; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INTERLEUKIN-4; LYMPHOMA, NON-HODGKIN; MONOCYTES; MYELOPOIESIS; NF-KAPPA B; PHAGOCYTOSIS; PROTEIN TRANSPORT; RECEPTORS, IMMUNOLOGIC; RECOMBINANT PROTEINS; RNA INTERFERENCE; RNA, SMALL INTERFERING; T-LYMPHOCYTES;

EID: 84990041441     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.1A0915-420RRR     Document Type: Article

References (38)

1. Mellman, I., Steinman, R. M. (2001) Dendritic cells: specialized and regulated antigen processing machines. Cell 106, 255-258.
2. Hammer, G. E., Ma, A. (2013) Molecular control of steady-state dendritic cell maturation and immune homeostasis. Annu. Rev. Immunol. 31, 743-791.
3. Anderson, K. J., Allen, R. L. (2009) Regulation of T-cell immunity by leucocyte immunoglobulin-like receptors: innate immune receptors for self on antigen-presenting cells. Immunology 127, 8-17.
4. Young, N. T., Waller, E. C., Patel, R., Roghanian, A., Austyn, J. M., Trowsdale, J. (2008) The inhibitory receptor LILRB1 modulates the differentiation and regulatory potential of human dendritic cells. Blood 111, 3090-3096.
5. Huang, J., Burke, P. S., Cung, T. D., Pereyra, F., Toth, I., Walker, B. D., Borges, L., Lichterfeld, M., Yu, X. G. (2010) Leukocyte immunoglobulinlike receptors maintain unique antigen-presenting properties of circulating myeloid dendritic cells in HIV-1-infected elite controllers. J. Virol. 84, 9463-9471.
6. Mori, Y., Tsuji, S., Inui, M., Sakamoto, Y., Endo, S., Ito, Y., Fujimura, S., Koga, T., Nakamura, A., Takayanagi, H., Itoi, E., Takai, T. (2008) Inhibitory immunoglobulin-like receptors LILRB and PIR-B negatively regulate osteoclast development. J. Immunol. 181, 4742-4751.
7. Chang, C. C., Ciubotariu, R., Manavalan, J. S., Yuan, J., Colovai, A. I., Piazza, F., Lederman, S., Colonna, M., Cortesini, R., Dalla-Favera, R., Suciu-Foca, N. (2002) Tolerization of dendritic cells by TS cells: the crucial role of inhibitory receptors ILT3 and ILT4. Nat. Immunol. 3, 237-243.
8. Cao, W., Rosen, D. B., Ito, T., Bover, L., Bao, M., Watanabe, G., Yao, Z., Zhang, L., Lanier, L. L., Liu, Y. J. (2006) Plasmacytoid dendritic cellspecific receptor ILT7-Fc eRIg inhibits Toll-like receptor-induced interferon production. J. Exp. Med. 203, 1399-1405.
9. Ma, G., Pan, P. Y., Eisenstein, S., Divino, C. M., Lowell, C. A., Takai, T., Chen, S. H. (2011) Paired immunoglobin-like receptor-B regulates the suppressive function and fate of myeloid-derived suppressor cells. Immunity 34, 385-395.
10. Youn, J. I., Gabrilovich, D. I. (2010) The biology of myeloid-derived suppressor cells: the blessing and the curse of morphological and functional heterogeneity. Eur. J. Immunol. 40, 2969-2975.
11. Zhang, W., Liang, S., Wu, J., Horuzsko, A. (2008) Human inhibitory receptor immunoglobulin-like transcript 2 amplifies CD11b+Gr1+ myeloid-derived suppressor cells that promote long-term survival of allografts. Transplantation 86, 1125-1134.
12. Oshima, S., Turer, E. E., Callahan, J. A., Chai, S., Advincula, R., Barrera, J., Shifrin, N., Lee, B., Benedict Yen, T. S., Woo, T., Malynn, B. A., Ma, A. (2009) ABIN-1 is a ubiquitin sensor that restricts cell death and sustains embryonic development. Nature 457, 906-909.
13. Lin, Y., Gustafson, M. P., Bulur, P. A., Gastineau, D. A., Witzig, T. E., Dietz, A. B. (2011) Immunosuppressive CD14+HLA-DRlow/2 monocytes in B-cell non-Hodgkin lymphoma. Blood 117, 872-881.
14. Gasparini, C., Feldmann, M. (2012) NF-kB as a target for modulating inflammatory responses. Curr. Pharm. Des. 18, 5735-5745.
15. van de Laar, L., van den Bosch, A., van der Kooij, S. W., Janssen, H. L., Coffer, P. J., van Kooten, C., Woltman, A. M. (2010) A nonredundant role for canonical NF-kB in human myeloid dendritic cell development and function. J. Immunol. 185, 7252-7261.
16. Dudek, A. M., Martin, S., Garg, A. D., Agostinis, P. (2013) Immature, semi-mature, and fully mature dendritic cells: toward a DC-cancer cells interface that augments anticancer immunity. Front. Immunol. 4, 438.
17. Gao, L., Coope, H., Grant, S., Ma, A., Ley, S. C., Harhaj, E. W. (2011) ABIN1 protein cooperates with TAX1BP1 and A20 proteins to inhibit antiviral signaling. J. Biol. Chem. 286, 36592-36602.
18. Verstrepen, L., Carpentier, I., Beyaert, R. (2014) The biology of A20- binding inhibitors of NF-kB activation (ABINs). Adv. Exp. Med. Biol. 809, 13-31.
19. Zhou, J., Wu, R., High, A. A., Slaughter, C. A., Finkelstein, D., Rehg, J. E., Redecke, V., Häcker, H. (2011) A20-binding inhibitor of NF-kB (ABIN1) controls Toll-like receptor-mediated CCAAT/enhancer-binding protein b activation and protects from inflammatory disease. Proc. Natl. Acad. Sci. U. S. A. 108, E998-E1006.
20. Nanda, S. K., Venigalla, R. K., Ordureau, A., Patterson-Kane, J. C., Powell, D. W., Toth, R., Arthur, J. S., Cohen, P. (2011) Polyubiquitin binding to ABIN1 is required to prevent autoimmunity. J. Exp. Med. 208, 1215-1228.
21. Callahan, J. A., Hammer, G. E., Agelides, A., Duong, B. H., Oshima, S., North, J., Advincula, R., Shifrin, N., Truong, H. A., Paw, J., Barrera, J., DeFranco, A., Rosenblum, M. D., Malynn, B. A., Ma, A. (2013) Cutting edge: ABIN-1 protects against psoriasis by restricting MyD88 signals in dendritic cells. J. Immunol. 191, 535-539.
22. Han, J. W., Zheng, H. F., Cui, Y., Sun, L. D., Ye, D. Q., Hu, Z., Xu, J. H., Cai, Z. M., Huang, W., Zhao, G. P., Xie, H. F., Fang, H., Lu, Q. J., Xu, J. H., Li, X. P., Pan, Y. F., Deng, D. Q., Zeng, F. Q., Ye, Z. Z., Zhang, X. Y., Wang, Q. W., Hao, F., Ma, L., Zuo, X. B., Zhou, F. S., Du, W. H., Cheng, Y. L., Yang, J. Q., Shen, S. K., Li, J., Sheng, Y. J., Zuo, X. X., Zhu, W. F., Gao, F., Zhang, P. L., Guo, Q., Li, B., Gao, M., Xiao, F. L., Quan, C., Zhang, C., Zhang, Z., Zhu, K. J., Li, Y., Hu, D. Y., Lu, W. S., Huang, J. L., Liu, S. X., Li, H., Ren, Y. Q., Wang, Z. X., Yang, C. J., Wang, P. G., Zhou, W. M., Lv, Y. M., Zhang, A. P., Zhang, S. Q., Lin, D., Li, Y., Low, H. Q., Shen, M., Zhai, Z. F., Wang, Y., Zhang, F. Y., Yang, S., Liu, J. J., Zhang, X. J. (2009) Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus. Nat. Genet. 41, 1234-1237.
23. Gateva, V., Sandling, J. K., Hom, G., Taylor, K. E., Chung, S. A., Sun, X., Ortmann, W., Kosoy, R., Ferreira, R. C., Nordmark, G., Gunnarsson, I., Svenungsson, E., Padyukov, L., Sturfelt, G., Jönsen, A., Bengtsson, A. A., Rantapää-Dahlqvist, S., Baechler, E. C., Brown, E. E., Alarcón, G. S., Edberg, J. C., Ramsey-Goldman, R., McGwin, Jr., G., Reveille, J. D., Vilá, L. M., Kimberly, R. P., Manzi, S., Petri, M. A., Lee, A., Gregersen, P. K., Seldin, M. F., Rönnblom, L., Criswell, L. A., Syvänen, A. C., Behrens, T. W., Graham, R. R. (2009) A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus. Nat. Genet. 41, 1228-1233.
24. Nair, R. P., Duffin, K. C., Helms, C., Ding, J., Stuart, P. E., Goldgar, D., Gudjonsson, J. E., Li, Y., Tejasvi, T., Feng, B. J., Ruether, A., Schreiber, S., Weichenthal, M., Gladman, D., Rahman, P., Schrodi, S. J., Prahalad, S., Guthery, S. L., Fischer, J., Liao, W., Kwok, P. Y., Menter, A., Lathrop, G. M., Wise, C. A., Begovich, A. B., Voorhees, J. J., Elder, J. T., Krueger, G. G., Bowcock, A. M., Abecasis, G. R.; Collaborative Association Study of Psoriasis. (2009) Genome-wide scan reveals association of psoriasis with IL-23 and NF-kB pathways. Nat. Genet. 41, 199-204.
25. Sun, L. D., Cheng, H., Wang, Z. X., Zhang, A. P., Wang, P. G., Xu, J. H., Zhu, Q. X., Zhou, H. S., Ellinghaus, E., Zhang, F. R., Pu, X. M., Yang, X. Q., Zhang, J. Z., Xu, A. E., Wu, R. N., Xu, L. M., Peng, L., Helms, C. A., Ren, Y. Q., Zhang, C., Zhang, S. M., Nair, R. P., Wang, H. Y., Lin, G. S., Stuart, P. E., Fan, X., Chen, G., Tejasvi, T., Li, P., Zhu, J., Li, Z. M., Ge, H. M., Weichenthal, M., Ye, W. Z., Zhang, C., Shen, S. K., Yang, B. Q., Sun, Y. Y., Li, S. S., Lin, Y., Jiang, J. H., Li, C. T., Chen, R. X., Cheng, J., Jiang, X., Zhang, P., Song, W. M., Tang, J., Zhang, H. Q., Sun, L., Cui, J., Zhang, L. J., Tang, B., Huang, F., Qin, Q., Pei, X. P., Zhou, A. M., Shao, L. M., Liu, J. L., Zhang, F. Y., Du, W. D., Franke, A., Bowcock, A. M., Elder, J. T., Liu, J. J., Yang, S., Zhang, X. J. (2010) Association analyses identify six new psoriasis susceptibility loci in the Chinese population. Nat. Genet. 42, 1005-1009.
26. Allanore, Y., Saad, M., Dieudé, P., Avouac, J., Distler, J. H., Amouyel, P., Matucci-Cerinic, M., Riemekasten, G., Airo, P., Melchers, I., Hachulla, E., Cusi, D., Wichmann, H. E., Wipff, J., Lambert, J. C., Hunzelmann, N., Tiev, K., Caramaschi, P., Diot, E., Kowal-Bielecka, O., Valentini, G., Mouthon, L., Czirják, L., Damjanov, N., Salvi, E., Conti, C., Müller, M., Müller-Ladner, U., Riccieri, V., Ruiz, B., Cracowski, J. L., Letenneur, L., Dupuy, A. M., Meyer, O., Kahan, A., Munnich, A., Boileau, C., Martinez, M. (2011) Genome-wide scan identifies TNIP1, PSORS1C1, and RHOB as novel risk loci for systemic sclerosis. PLoS Genet. 7, e1002091.
27. Bossini-Castillo, L., Martin, J. E., Broen, J., Simeon, C. P., Beretta, L., Gorlova, O. Y., Vonk, M. C., Ortego-Centeno, N., Espinosa, G., Carreira, P., García de la Peña, P., Oreiro, N., Román-Ivorra, J. A., Castillo, M. J., González-Gay, M. A., Sáez-Comet, L., Castellví, I., Schuerwegh, A. J., Voskuyl, A. E., Hoffmann-Vold, A. M., Hesselstrand, R., Nordin, A., Lunardi, C., Scorza, R., van Laar, J. M., Shiels, P. G., Herrick, A., Worthington, J., Fonseca, C., Denton, C., Tan, F. K., Arnett, F. C., Assassi, S., Koeleman, B. P., Mayes, M. D., Radstake, T. R., Martin, J.; Spanish Scleroderma Group. (2013) Confirmation of TNIP1 but not RHOB and PSORS1C1 as systemic sclerosis risk factors in a large independent replication study. Ann. Rheum. Dis. 72, 602-607.
28. Gregersen, P. K., Kosoy, R., Lee, A. T., Lamb, J., Sussman, J., McKee, D., Simpfendorfer, K. R., Pirskanen-Matell, R., Piehl, F., Pan-Hammarstrom, Q., Verschuuren, J. J., Titulaer, M. J., Niks, E. H., Marx, A., Ströbel, P., Tackenberg, B., Pütz, M., Maniaol, A., Elsais, A., Tallaksen, C., Harbo, H. F., Lie, B. A., Raychaudhuri, S., de Bakker, P. I., Melms, A., Garchon, H. J., Willcox, N., Hammarstrom, L., Seldin, M. F. (2012) Risk for myasthenia gravis maps to a 151Pro→Ala change in TNIP1 and to human leukocyte antigen-B*08. Ann. Neurol. 72, 927-935.
29. Jitschin, R., Braun, M., Büttner, M., Dettmer-Wilde, K., Bricks, J., Berger, J., Eckart, M. J., Krause, S. W., Oefner, P. J., Le Blanc, K., Mackensen, A., Mougiakakos, D. (2014) CLL-cells induce IDOhi CD14+HLA-DRlo myeloid-derived suppressor cells that inhibit T-cell responses and promote TRegs. Blood 124, 750-760.
30. Vuk-Pavlović, S., Bulur, P. A., Lin, Y., Qin, R., Szumlanski, C. L., Zhao, X., Dietz, A. B. (2010) Immunosuppressive CD14+HLA-DRlow/2 monocytes in prostate cancer. Prostate 70, 443-455.
31. Gustafson, M. P., Lin, Y., New, K. C., Bulur, P. A., O’Neill, B. P., Gastineau, D. A., Dietz, A. B. (2010) Systemic immune suppression in glioblastoma: the interplay between CD14+HLA-DRlo/neg monocytes, tumor factors, and dexamethasone. Neuro-oncol. 12, 631-644.
32. Mao, Y., Poschke, I., Wennerberg, E., Pico de Coaña, Y., Egyhazi Brage, S., Schultz, I., Hansson, J., Masucci, G., Lundqvist, A., Kiessling, R. (2013) Melanoma-educated CD14+ cells acquire a myeloid-derived suppressor cell phenotype through COX-2-dependent mechanisms. Cancer Res. 73, 3877-3887.
33. Rudolph, B. M., Loquai, C., Gerwe, A., Bacher, N., Steinbrink, K., Grabbe, S., Tuettenberg, A. (2014) Increased frequencies of CD11b+CD33+CD14+HLA-DRlow myeloid-derived suppressor cells are an early event in melanoma patients. Exp. Dermatol. 23, 202-204.
34. Marchesi, M., Andersson, E., Villabona, L., Seliger, B., Lundqvist, A., Kiessling, R., Masucci, G. V. (2013) HLA-dependent tumour development: a role for tumour associate macrophages? J. Transl. Med. 11, 247.
35. Rouas-Freiss, N., Moreau, P., LeMaoult, J., Carosella, E. D. (2014) The dual role of HLA-G in cancer. J. Immunol. Res. 2014, 359748.
36. Naji, A., Menier, C., Maki, G., Carosella, E. D., Rouas-Freiss, N. (2012) Neoplastic B-cell growth is impaired by HLA-G/ILT2 interaction. Leukemia 26, 1889-1892.
37. Ramirez, V. P., Gurevich, I., Aneskievich, B. J. (2012) Emerging roles for TNIP1 in regulating post-receptor signaling. Cytokine Growth Factor Rev. 23, 109-118.
38. Favier, B., HoWangYin, K. Y., Wu, J., Caumartin, J., Daouya, M., Horuzsko, A., Carosella, E. D., LeMaoult, J. (2011) Tolerogenic function of dimeric forms of HLA-G recombinant proteins: a comparative study in vivo. PLoS One 6, e21011.